|
WHAT'S THIS?
|
COMMENTARY
|
This section collates links to previously published articles and news stories.
The five latest additions are highlighted below, the rest can be found via the menu on the left.
|
|
|
Open access publication fees at the BMJ
Published 17 August 2010
The BMJ announces they are adopting the "author pays" model for research, but only when funders have pledged to pick up the bill
[Link to original source material]
|
|
|
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Published 3 August 2010
A new study in Annals of Internal Medicine suggests that drug studies funded by industry are significantly more likely to have favourable outcomes than those funded by the government or non-profit groups.
[Link to original source material]
|
|
|
Don't Mess with the DSMB
Published 29 July 2010
Jeffrey M. Drazen, M.D. and Alastair J.J. Wood writing in the NEJM, call for fundamental changes in the way DSMBs (data and safety monitoring boards) are constituted, are funded, and report, regardless of whether there is a commercial or a public sponsor. They propose that to prevent sponsors from interfering with an ongoing study, the trial steering committee would report only to the DSMB.
[Link to original source material]
|
|
|
Disclosing Industry Relationships — Toward an Improved Federal Research Policy
Published 14 July 2010
Eric G. Campbell and Darren E. Zinner writing in the NEJM, review moves for more stringent requirements for academic researchers to reveal industry payments.
[Link to original source material]
|
|
|
Disclosing Industry Relationships — Toward an Improved Federal Research Policy
Published 14 July 2010
Eric G. Campbell and Darren E. Zinner writing in the NEJM, review moves for more stringent requirements for academic researchers to reveal industry payments.
[Link to original source material]
|
|
WHAT ELSE?
|
NEWS ALERT!
Do you want to be alerted to important news and events relevant to publication planning?
Sign up here.
|
|
|
|
|
|
[View details here]
Strategic Medcomms Forum 2010: Reshaping the healthcare conversation
30 September 2010
Oxford University Musuem
The first of a series of annual events where we consider how the global medical and pharmaceutical industry engages with its stakeholders and we identify and debate future directions and implications for medical-marketing activity.
[View details here]
Organized by NetworkPharma.
|
|
|
|
|
